amiodarone has been researched along with Dizzyness in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including neurotoxicity." | 7.01 | Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. ( Dumic, I; Kaur, A; Kaur, P; Khaliq, W; Singh, A; Sinha, A, 2023) |
"Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including neurotoxicity." | 3.01 | Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. ( Dumic, I; Kaur, A; Kaur, P; Khaliq, W; Singh, A; Sinha, A, 2023) |
"Recent infection was present in 40." | 1.39 | Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance. ( Ajrouche, R; Al-Hajje, A; Awada, S; El-Helou, N; Rachidi, S; Salameh, P; Zein, S, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kaur, P | 1 |
Kaur, A | 1 |
Sinha, A | 1 |
Khaliq, W | 1 |
Dumic, I | 1 |
Singh, A | 1 |
El-Helou, N | 1 |
Al-Hajje, A | 1 |
Ajrouche, R | 1 |
Awada, S | 1 |
Rachidi, S | 1 |
Zein, S | 1 |
Salameh, P | 1 |
1 review available for amiodarone and Dizzyness
Article | Year |
---|---|
Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Ataxia; Atrial Fibrillation; Dizziness; Drug- | 2023 |
1 other study available for amiodarone and Dizzyness
Article | Year |
---|---|
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Inflammatory Agen | 2013 |